{"id":201,"date":"2026-01-19T13:35:05","date_gmt":"2026-01-19T12:35:05","guid":{"rendered":"https:\/\/dendropharm.develop-stage.de\/?page_id=201"},"modified":"2026-02-02T14:19:30","modified_gmt":"2026-02-02T13:19:30","slug":"historie","status":"publish","type":"page","link":"https:\/\/www.dendropharm.de\/en\/historie\/","title":{"rendered":"Historie"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_fullwidth_image src=”https:\/\/www.dendropharm.de\/wp-content\/uploads\/Historie-scaled.jpg” title_text=”Historie” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.5″ _module_preset=”default” custom_padding=”||3px|||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_heading title=”Unternehmensgeschichte” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”3_4,1_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”3_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_accordion _builder_version=”4.27.5″ _module_preset=”default” toggle_font=”|600|||||||” toggle_font_size=”18px” body_font_size=”18px” body_line_height=”1.9em” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″][et_pb_accordion_item title=”Oktober 2025 – Fokus Innovationspreis” open=”on” _builder_version=”4.27.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n

\"\"<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Januar 2023 – Veterinary Manufacturing License” open=”off” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n

DendroPharm obtains the manufacturing license for analytics and release of veterinary medical products<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Januar 2022 – GMP Approval from LaGeSo” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

Certification according GMP by the state authority LaGeSo<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Januar 2019 – New Premises for DendroPharm” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm moves to a new location in the Lankwitzer Stra\u00dfe with 800 m2 of cleanroom, laboratory, storage and production facilities.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Oktober 2017 – DendroPharm Joins NetPhaSol Network” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm becomes a member of the \u201cNetwork for Pharma Solutions\u201d<\/a> NetPhaSol. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus is on first value chain stages of drug development \u2013 however, further development stages are not excluded. DendroPharm is now broadening NetPhaSol\u00b4s profile with its expertise in CMS Nanocarriers and dermal drug delivery.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Dezember 2016 – DendroPharm Wins Innovation Award” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]DendroPharm wins the Innovation Award Berlin-Brandenburg<\/a>.
\nThe Innovation Award Berlin-Brandenburg is one of the most prestigious awards for novel products and is awarded annually. 120 innovative products by large, small and medium enterprises have entered the competition in 2016. Of those, 5 innovations have won awards. DendroPharm GmbH develops nanocarriers which enable a highly efficient transdermal drug transfer for both lipiphilic and hydrophilic compounds. DendroSol\u00ae nanocarriers are non-toxic, biodegradable and do not irritate the skin. This results in significantly reduced side effects. The technology has been developed together with Prof. Rainer Haag from the Freie Universit\u00e4t Berlin. It enables patients to switch their daily medication from oral to transdermal and thus prevent gastrological side effects.[\/et_pb_accordion_item][et_pb_accordion_item title=”November 2016 – Dr. Mor\u00e9 Presents on Polymer-Based Nanomaterials” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

Presentation: \u201cPolymerbasierte Nanomaterialien \u2013 Anwendungsm\u00f6glichkeiten und regulatorische H\u00fcrden\u201d Dr. Sam Dylan Mor\u00e9, DendroPharm GmbH.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”April 2016 – Partnership with ViscoTec on GMP Filling” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm becomes reference client of ViscoTec`s GMP grade filling technology for highly viscous semisolid drugs | pdf
Viscotech<\/a> is a leading German manufacturer of high precision dosing pump equipment. This technology will enable DendroPharm to offer its clients GMP grade investigational products for clinical trials of highly potent drugs and semi-solids from 2017 onwards.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”September 2015 – DendroPharm Achieves ISO 9001:2008 Certification” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm\u2019s quality management system successfully passed the certification by T\u00dcV-S\u00dcD according to the norm ISO 9001:2008. The scope is as follows: Research and development of nanomaterials and nanocarriers as pharmaceutical excipients, as well as of galenic products; production and purification of nanomaterials and nanocarriers for research purposes; production of nanomaterials and nanocarriers for veterinary products.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Dezember 2014 – DendroPharm Qualifies for BAFA Subsidy” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm qualifies for inclusion in the BAFA program for a 20% subsidy for direct private investments from 10.000 \u20ac. If interested, please get in touch with the management.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”September 29, 2014 – DendroPharm Finalist for Technology Transfer Award 2014″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm finalist for the \u201ctechnology transfer award 2014 of the Berliner Sparkasse\u201d<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”April 14, 2014 – DendroPharm Takes Second Place in Business Plan Competition” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm achieved the second place in the \u201cBusinessplan Wettbewerb Berlin-Brandenburg\u201d<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Dezember 11, 2013 – DendroPharm Licenses Two Drug Delivery Patents” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm licences two patents about controlled drug delivery from the Freie Universit\u00e4t Berlin.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Oktober 28, 2013 – DendroPharm Experts Contribute to FU Berlin Program” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

Dr. Henrik Luessen and Dr. Sam Dylan Mor\u00e9 support the \u201cEntrepreneurship Lecture Program\u201d of the Freie Universit\u00e4t Berlin. Dr. Henrik Luessen has been invited to give the starting lecture.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”September 13, 2013 – DendroPharm Raises \u20ac1.2M in First Financing Round” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm GmbH acquired 1.2 Mio Euro in the first financing round by sucessfully qualifying for the \u201cProFit\u201d start-up program of the IBB \u2013 Investitionsbank Berlin and the ERDF Fund of the European Union.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Februar 14, 2013 – Science4Life 2013: DendroPharm in Top 20″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

DendroPharm was among the 20 best teams of the \u201cScience4Life\u201d concept phase in 2013. | More \u2026<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”August 14, 2012 – DendroPharm Reaches Second Round in BMBF GoBio” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” open=”off”]<\/p>\n

The team of DendroPharm GmbH reached the second evaluation round of the \u201cBMBF GoBio\u201d competition.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=yJ1jKXkZhTY” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

DendroPharm obtains the manufacturing license for analytics and release of veterinary medical productsCertification according GMP by the state authority LaGeSoDendroPharm moves to a new location in the Lankwitzer Stra\u00dfe with 800 m2 of cleanroom, laboratory, storage and production facilities.DendroPharm becomes a member of the \u201cNetwork for Pharma Solutions\u201d NetPhaSol. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus is on first value chain stages of drug development \u2013 however, further development stages are not excluded. DendroPharm is now broadening NetPhaSol\u00b4s profile with its expertise in CMS Nanocarriers and dermal drug delivery.DendroPharm wins the Innovation Award Berlin-Brandenburg. The Innovation Award Berlin-Brandenburg is one of the most prestigious awards for novel products and is awarded annually. 120 innovative products by large, small and medium enterprises have entered the competition in 2016. Of those, 5 innovations have won awards. DendroPharm GmbH develops nanocarriers which enable a highly efficient transdermal drug transfer for both lipiphilic and hydrophilic compounds. DendroSol\u00ae nanocarriers are non-toxic, biodegradable and do not irritate the skin. This results in significantly reduced side effects. The technology has been developed together with Prof. Rainer Haag from the Freie […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-201","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/pages\/201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/comments?post=201"}],"version-history":[{"count":15,"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/pages\/201\/revisions"}],"predecessor-version":[{"id":458,"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/pages\/201\/revisions\/458"}],"wp:attachment":[{"href":"https:\/\/www.dendropharm.de\/en\/wp-json\/wp\/v2\/media?parent=201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}